Investing.com - Gilead (NASDAQ:GILD) reported fourth quarter earnings that missed analysts' expectations on Monday and revenue that topped forecasts.
The firm reported earnings per share of $1.44 on revenue of $5.8B. Analysts polled by Investing.com expected EPS of $1.71 on revenue of $5.51B. That compared to EPS of $1.78 on revenue of $5.95B in the same period a year earlier. The company had reported EPS of $1.84 on revenue of $5.6B in the previous quarter.
Gilead shares lost 1.07% to trade at $69.30 in after-hours trade following the report.
Gilead shares lost 1.07% to trade at $69.30 in after-hours trade following the report.
For the year, Gilead shares are up 11.99%, outperforming the S&P 500 which is up 10.01% year to date.
Gilead follows other major Healthcare sector earnings this month
On Tuesday, January 22, 2019, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings beat analyst's expectations on Tuesday, January 29, 2019, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.63 on revenue of $13.9B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar